Kilitch Drugs (India) Limited
Kilitch Drugs (India) Limited engages in the development and operation of the pharmaceutical business in India and internationally. The company offers various parenteral, nasal, and topical products, such as liquid ampoules, vials, dry powder injectables, and metered nasal drops for gastroenterology, non-steroidal anti-inflammatory, anticonvulsant/antiepileptic, anti-malarial, aminoglycoside, ant… Read more
Kilitch Drugs (India) Limited (KILITCH) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.025x
Based on the latest financial reports, Kilitch Drugs (India) Limited (KILITCH) has a cash flow conversion efficiency ratio of -0.025x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹-66.20 Million) by net assets (₹2.64 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Kilitch Drugs (India) Limited - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Kilitch Drugs (India) Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Kilitch Drugs (India) Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kilitch Drugs (India) Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hotel Holiday Garden
TW:2702
|
0.034x |
|
P5X0
F:P5X0
|
-0.530x |
|
SAREUM HLDGS LS-0125
F:RYH0
|
N/A |
|
Kwang Myung El
KO:017040
|
0.147x |
|
ASTech Co., Ltd.
KQ:453860
|
-0.018x |
|
Capital Properties Inc
OTCQX:CPTP
|
0.046x |
|
Western Capital Resources Inc
OTCQB:WCRS
|
0.022x |
|
RESAAS Services Inc
OTCQB:RSASF
|
-0.022x |
Annual Cash Flow Conversion Efficiency for Kilitch Drugs (India) Limited (2006–2025)
The table below shows the annual cash flow conversion efficiency of Kilitch Drugs (India) Limited from 2006 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹2.00 Billion | ₹175.42 Million | 0.088x | +10608.11% |
| 2024-03-31 | ₹1.76 Billion | ₹-1.46 Million | -0.001x | -104.85% |
| 2023-03-31 | ₹1.51 Billion | ₹25.86 Million | 0.017x | -58.34% |
| 2022-03-31 | ₹1.40 Billion | ₹57.83 Million | 0.041x | -88.31% |
| 2021-03-31 | ₹1.29 Billion | ₹456.59 Million | 0.353x | +1034.35% |
| 2020-03-31 | ₹1.20 Billion | ₹37.45 Million | 0.031x | +1216.09% |
| 2019-03-31 | ₹1.23 Billion | ₹2.91 Million | 0.002x | -81.28% |
| 2018-03-31 | ₹1.13 Billion | ₹14.23 Million | 0.013x | +13.89% |
| 2017-03-31 | ₹1.01 Billion | ₹11.21 Million | 0.011x | -93.01% |
| 2016-03-31 | ₹1.09 Billion | ₹172.33 Million | 0.159x | +349.49% |
| 2015-03-31 | ₹1.20 Billion | ₹-76.18 Million | -0.064x | +75.42% |
| 2014-03-31 | ₹1.20 Billion | ₹-310.84 Million | -0.259x | -2155.68% |
| 2013-03-31 | ₹1.19 Billion | ₹14.97 Million | 0.013x | +104.95% |
| 2012-03-31 | ₹1.16 Billion | ₹-293.49 Million | -0.254x | -217.16% |
| 2011-03-31 | ₹858.72 Million | ₹186.05 Million | 0.217x | +3.92% |
| 2010-03-31 | ₹740.88 Million | ₹154.46 Million | 0.208x | +27.83% |
| 2009-03-31 | ₹643.97 Million | ₹105.03 Million | 0.163x | +120.74% |
| 2008-03-31 | ₹513.18 Million | ₹-403.48 Million | -0.786x | -189.85% |
| 2007-03-31 | ₹135.84 Million | ₹118.87 Million | 0.875x | +22.51% |
| 2006-03-31 | ₹116.74 Million | ₹83.39 Million | 0.714x | -- |